Abstract: A method of manufacturing a catalyst intermediate is provided. The method comprises: providing a slurry comprising a hydrous oxide of one or more of aluminium, cerium and zirconium; and contacting the slurry comprising a hydrous oxide with platinum group metal (PGM) ions to provide a PGM-containing slurry.

Abstract: In various aspects and embodiments the invention provides a method of preparing a cyclopentaoxasilinone, the method comprising contacting a siloxy-tethered 1,7-enyne with a thioether promoter. In another aspect, the invention provides a method of preparing a cyclopentaoxaborininone, the method comprising contacting a boronic ester-tethered 1,7-enyne with a thioether promoter.

Abstract: A lithium cell, in particular a lithium-metal and/or lithium-ion solid electrolyte-liquid electrolyte hybrid cell, is described that includes an anode layer and a cathode layer. A separator layer is situated between the anode layer and the cathode layer. The cathode layer and/or the separator layer and/or the anode layer includes at least one solvent and/or at least one lithium conductive salt. To improve the rapid charge capacity of the cell, a dividing layer is situated between the cathode layer and the separator layer, which dividing layer is conductive for lithium ions and is impermeable for the at least one solvent of the cathode layer and/or of the separator layer and/or of the anode layer, and/or is impermeable for lithium conductive salt anions of the at least one lithium conductive salt of the cathode layer and/or of the separator layer and/or of the anode layer.

Abstract: In various aspects and embodiments the invention provides a method of preparing a cyclopentaoxasilinone, the method comprising contacting a siloxy-tethered 1,7-enyne with a thioether promoter. In another aspect, the invention provides a method of preparing a cyclopentaoxaborininone, the method comprising contacting a boronic ester-tethered 1,7-enyne with a thioether promoter.

Abstract: A lithium cell, in particular a lithium-metal and/or lithium-ion solid electrolyte-liquid electrolyte hybrid cell, is described that includes an anode layer and a cathode layer. A separator layer is situated between the anode layer and the cathode layer. The cathode layer and/or the separator layer and/or the anode layer includes at least one solvent and/or at least one lithium conductive salt. To improve the rapid charge capacity of the cell, a dividing layer is situated between the cathode layer and the separator layer, which dividing layer is conductive for lithium ions and is impermeable for the at least one solvent of the cathode layer and/or of the separator layer and/or of the anode layer, and/or is impermeable for lithium conductive salt anions of the at least one lithium conductive salt of the cathode layer and/or of the separator layer and/or of the anode layer.

Abstract: A series of pharmaceutical compositions which contain 4-aminoalkyl-2(3H)-indolones has been demonstrated to have D.sub.2 -agonist activity useful for treating congestive heart failure and hypertension. A representative ingredient of the compositions is 4-di-n-propylaminoethyl-2(3H)-indolone or a salt thereof.

Abstract: A series of new chemical compounds which are 4-aminoalkyl-2(3H)-indolones has been demonstrated to be D.sub.2 -agonists useful for treating hypertension. A representative compound of the series is 4-di-n-propylaminoethyl-2(3H)-indolone.

Abstract: A group of 1-phenyl-1H-3-benzazepines whose structures are characterized by having a functional thio containing group on the 1-phenyl moiety and which have pronounced peripheral and diminished central dopaminergic activity. This activity is manifested in an anti-hypertensive effect in humans. Particular species of this group include 6-chloro-7,8-dihydroxy-1-p-methylthiophenyl-2,3,4,5-tetrahydro-1H-3-benzaz epine and its derivatives which have dopaminergic activity.

Abstract: 4-Sulfanilamidothiazole having antibacterial activity is prepared from the previously unknown 4-aminothiazole.

Abstract: New methods and compositions for inducing polyphagia in growing or fattening meat producing animals such as sheep or cattle are described using as active ingredients certain carbamates, ureas, oxyureas or ureides. The active ingredients are used most usefully at subhypnotic quantities admixed in animal feed.

Abstract: 4-Aminothiazole is prepared in stable useful form by alkaline hydrolysis of 4-trifluoroacetamidothiazole. Also prepared are 4-sulfathiazole and 2-(4-thaizolyl)-indazole.

Abstract: New methods and compositions for inducing polyphagia in growing or fattening meat producing animals such as sheep or cattle are described using as active ingredients tertiary alcohols or the corresponding carbamates, ureas, oxyureas or ureides. The active ingredients are used most usefully at sub-hypnotic quantities admixed in animal feed.